· Authored a comprehensive Institutional Review Board (IRB) proposal for a pilot clinical study that has recruited 50+ participants aimed at correlating active and passive sensor data for depressive disorders· Presented to a audience of 100+ professionals on methods of monitoring cardiovascular diseases and mental health illnesses at the International Neuropsychological Society (INS) 2022 conference

· Developing and implementing automated trackers in Excel to monitor staffing levels, overtime utilization, costs projections, and related metrics, providing critical insights for executive decision-making to decrease costs by 5 − 10%· Conducting comprehensive process mapping of the utilization and billing processes for single-use duodenoscopes in endoscopy, preventing mistakes and losses of up to $250, 000+ per year

· Conceived an innovative model and leveraged collective expertise to develop innovative approach to address the financial challenges associated with financing ultra−rare/rare disease therapeutics· Conducted in-depth market research on 14 different CAR-T/gene therapy, including industry trends, competitive landscape, and reimbursement models

· Designed and established western blot protocols for evaluating the internalization kinetics of receptor targets such as CD220, ASHA1, CD71, etc. across 15 different tissues· Performed literature and industry review to identify 2 different targets for siRNA delivery

· Guided 300+ patients through their visit to the practice: completed patient intake, scribed during the visit, and explained dermatological procedures and medications· Compiled and organized over 100+ pages of documentation, video media, patents, etc for a novel laser-based injection device to pursue FDA approval (De Novo classification, and Investigational Device Exemption (IDE))· Authored 2 case reports that were accepted at the American Academy of Dermatology (AAD) 2023 annual meeting

Isolated animal tissue performed to c-FOS immunohistochemistry, and in situ hybridization to help characterize the anxiolytic circuit in relation to the BNST

Identified and targeted fungal pathogen (Aspergillus N.) using in silico (MOE) and in vitro (SDS-PAGE, protein chromatography, pNPP assay, etc.) methods to ultimately protect crops from fungal pathogens.